Absence of p53 in a mouse mammary tumor model promotes tumor cell proliferation without affecting apoptosis

作者: Laura Attardi , Harold E. Varmus , Lucy A. Godley , Daniel Medina , Tyler Jacks

DOI:

关键词:

摘要: Loss or mutation of p53 may have multiple biological and genetic effects that result in accelerated tumor progression. some tumors has been correlated with a marked decrease cell apoptosis. loss also accelerate growth through an increase proliferation rates. To examine the on progression controlled experimental context, we previously crossed p53-deficient mice to mammary tumor-susceptible Wnt-1 transgenic (TG) mice. The resulting female TG offspring this cross all developed tumors, regardless status (p53+/+, p53+/-, p53-/-). However, p53-/- much sooner than their p53+/+ counterparts. In report, demonstrate average rates missing (p53-/-) losing (p53+/- heterozygosity) are compared both wild-type alleles (p53+/+). This rate appears be due primarily increases proliferation. Tumor apoptotic levels were modest not measurably different presence absence p53. These results differ substantially from other mouse models which was closely attenuated Thus, mechanisms by influences differ, depending tissue type and/or oncogenic pathways involved.

参考文章(53)
B. C. Giovanella, M. A. Tainsky, M. Harvey, R. S. Weiss, A. T. Sands, A. Bradley, R. W. Wiseman, M. E. Hegi, L. A. Donehower, P. Pantazis, In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene. ,vol. 8, pp. 2457- 2467 ,(1993)
M S Greenblatt, W P Bennett, M Hollstein, C C Harris, Mutations in the p53 Tumor Suppressor Gene: Clues to Cancer Etiology and Molecular Pathogenesis Cancer Research. ,vol. 54, pp. 4855- 4878 ,(1994)
B. C. Giovanella, Michael A. Tainsky, Louise C. Strong, Sen Pathak, Sun O. Yim, Michael J. Siciliano, Grace Grant, Farideh Z. Bischoff, Spontaneous Abnormalities in Normal Fibroblasts from Patients with Li-Fraumeni Cancer Syndrome: Aneuploidy and Immortalization Cancer Research. ,vol. 50, pp. 7979- 7984 ,(1990)
Bonnie E. Miller, Gloria H. Heppner, Fred R. Miller, David Wilburn, Dominance of a tumor subpopulation line in mixed heterogeneous mouse mammary tumors. Cancer Research. ,vol. 48, pp. 5747- 5753 ,(1988)
B. Smith-Sørensen, Eivind Hovig, M. S. Greenblatt, Therese Sorlie, R. Montesano, M. Hollstein, C. C. Harris, K. Rice, R. Fuchs, T. Soussi, Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Research. ,vol. 22, pp. 3551- 3555 ,(1994)
U M Moll, A G Ostermeyer, R Haladay, B Winkfield, M Frazier, G Zambetti, Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage. Molecular and Cellular Biology. ,vol. 16, pp. 1126- 1137 ,(1996) , 10.1128/MCB.16.3.1126
Jorunn E. Eyfjörd, Rut Valgardsdottir, Margret Steinarsdottir, Helga M. Ögmundsdottir, Steinunn Thorlacius, Kesara Anamthawat-Jonsson, p53 abnormalities and genomic instability in primary human breast carcinomas. Cancer Research. ,vol. 55, pp. 646- 651 ,(1995)
S F Jue, R S Bradley, J A Rudnicki, H E Varmus, A M Brown, The mouse Wnt-1 gene can act via a paracrine mechanism in transformation of mammary epithelial cells. Molecular and Cellular Biology. ,vol. 12, pp. 321- 328 ,(1992) , 10.1128/MCB.12.1.321
Lars L. Vindeløv, Ib J. Christensen, Nis I. Nissen, A Detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis† Cytometry. ,vol. 3, pp. 323- 327 ,(1983) , 10.1002/CYTO.990030503